Panobinostat for treating multiple myeloma after at least 2 previous treatments

  • Technology appraisal guidance
  • TA380
  • Published: 
Download (PDF)

What has NICE said?

Panobinostat (Farydak), given with drugs called bortezomib and dexamethasone, is recommended as a possible treatment for people with multiple myeloma only if:

  • their disease has not responded to therapy, or responded but then gotten worse

  • they have already had at least 2 other treatments including bortezomib and an immunomodulatory drug.

What does this mean for me?

If you have multiple myeloma, and your doctor thinks that panobinostat is the right treatment, you should be able to have the treatment on the NHS.

Panobinostat should be available on the NHS within 3 months of the guidance being issued.

  • Information Standard